Date published: 2026-3-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

Imidaprilat (CAS 89371-44-8)

0.0(0)
Write a reviewAsk a question

Alternate Names:
(4S)-3-{(2S)-2-[N-((1S)-1-Carboxy-3-phenylpropyl)amino]propionyl}-1-methyl-2-oxoimidazolidine-4-carboxylic Acid; Imidapril Diacid
Application:
Imidaprilat is an ACE ihibitor
CAS Number:
89371-44-8
Molecular Weight:
377.39
Molecular Formula:
C18H23N3O6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Imidaprilat facilitates the investigation of ion metabolism and transport, and it aids in analyzing how certain substances might interact with the immune system. It has a high affinity for and selectively inhibits certain enzymes, which is relevant in the exploration of enzyme behavior and kinetics.Functioning as a guanylate cyclase inhibitor, imidaprilat interacts with this enzyme, for blood pressure regulation, by hindering its ability to convert guanosine triphosphate (GTP) into cyclic guanosine monophosphate (cGMP).


Imidaprilat (CAS 89371-44-8) References

  1. Protective effect of imidaprilat, a new angiotensin-converting enzyme inhibitor against 1-methyl-4-phenylpyridinium ion-induced *OH generation in rat striatum.  |  Obata, T. 1999. Eur J Pharmacol. 378: 39-45. PMID: 10478563
  2. Protective effect of imidaprilat, an angiotensin-converting enzyme inhibitor on *OH generation in rat myocardium.  |  Obata, T. and Yamanaka, Y. 1999. Biochim Biophys Acta. 1472: 62-70. PMID: 10572926
  3. Determination of imidapril and imidaprilat in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.  |  Mabuchi, M., et al. 1999. J Chromatogr B Biomed Sci Appl. 734: 145-53. PMID: 10574200
  4. Different inhibition of enalaprilat and imidaprilat on bradykinin metabolizing enzymes.  |  Sakamoto, K., et al. 2000. Life Sci. 67: 2159-65. PMID: 11045597
  5. Comparison of the effect of imidaprilat and ramiprilat on broncho-constriction and hypotension induced by bradykinin in guinea pigs.  |  Doi, H. and Narita, H. 2000. Inflamm Res. 49: 506-12. PMID: 11089901
  6. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.  |  Hosoya, K. and Ishimitsu, T. 2002. Cardiovasc Drug Rev. 20: 93-110. PMID: 12177688
  7. Imidaprilat suppresses nonylphenol and 1-methyl-4-phenylpyridinium ion (MPP+)-induced hydroxyl radical generation in rat striatum.  |  Obata, T. 2006. Neurosci Res. 54: 192-6. PMID: 16386813
  8. Imidaprilat, an angiotensin-converting enzyme inhibitor exerts neuroprotective effect via decreasing dopamine efflux and hydroxyl radical generation induced by bisphenol A and MPP+ in rat striatum.  |  Obata, T. 2006. Brain Res. 1071: 250-3. PMID: 16406270
  9. Imidaprilat inhibits matrix metalloproteinase-2 activity in human cardiac fibroblasts induced by interleukin-1beta via NO-dependent pathway.  |  Guo, XG., et al. 2008. Int J Cardiol. 126: 414-20. PMID: 18192036
  10. MMP-9 inhibition by ACE inhibitor reduces oxidized LDL-mediated foam-cell formation.  |  Kojima, C., et al. 2010. J Atheroscler Thromb. 17: 97-105. PMID: 20093780
  11. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.  |  Yamanaka, K., et al. 1996. J Pharm Sci. 85: 1234-7. PMID: 8923331
  12. Pharmacokinetic and pharmacodynamic study of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor, in spontaneously hypertensive rats.  |  Yamanaka, K., et al. 1997. J Pharm Biomed Anal. 15: 1851-9. PMID: 9278890
  13. Effect of .OH scavenging action by non-SH-containing angiotensin converting enzyme inhibitor imidaprilat using microdialysis.  |  Obata, T. and Yamanaka, Y. 1998. J Physiol Paris. 92: 1-4. PMID: 9638590

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Imidaprilat, 1 mg

sc-218591
1 mg
$500.00